The pharmaceutical giant released fresh trial data showing the drug helped obese or overweight type 2 diabetics lose an ...
New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback